Document is current
Any future updates will be listed below
-
Authors
Li, Tingting
Zhou, Bingjie
Dong, Haoyu
Lavillette, Dimitri
Li, Dianfan https://orcid.org/0000-0003-4729-4678
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82151215, 31870153)
National Key R&D Program of China (2020YFC0845900)
CAS president's international fellowship initiative (2020VBA0023)
Science and Technology Commission of Shanghai Municipality (22ZR1468300)
Shanghai Municipal Science and Technology Major Project (20431900402)
- License Information
-
More Information
Article History
Received: 19 December 2023
Revised: 4 January 2024
Accepted: 18 January 2024
First Online: 29 January 2024
Declarations
:
: Not applicable.
: Not applicable.
: A patent application for potential antibody therapy for the treatment of COVID-19 has been approved for FD20.
